PGNY — Progyny Inc. stock price and chart

PGNY

$28.58+2.66%

as of close, Oct 20, 2026

☾ AH $28.58 +2.66%

Progyny Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.007% of ONEQRussell 3000 · 0.003% of IWVUS Stock Market · 0.003% of VTI

PeersMOHCNCHUMCIELVCVS

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Oct 30, 2019

VolumeEEEEEEEEEEEE

20192021202320252026

15.020.025.030.035.040.045.050.055.060.0020.0M40.0M$28.58

2026-10-20

Price$28.58

MA20$27.94

MA50$24.28

Vol2.9M

What would $1,000 invested in PGNY be worth today? →

PGNY returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $28.58
YTD price return: +11.29%
YTD total return: +11.29%
Next earnings: Nov 5, 2026
Market cap: 2.2B2019-12 2.3B2026-10 2.2B-5.8% over the window
Enterprise value: 2.1B
Shares outstanding: 76.7M2017-12 5.7M2026-06 76.7M+1251.3% over the window
52W low: $16.10
52W high: $33.07
From 52W high: -13.56%
From 52W low: +77.52%
52W range: 74%

Volume

Rel volume: 1.07×
30D volume: 1.2M
30D $ vol: 31M

Fundamentals

Sales (ttm): 1.3B2017-12 48.6M2026-06 1.3B+2597.9% over the window
Sales/share: $17.082017-12 $8.562026-06 $17.08+99.6% over the window
EPS (ttm): $0.922017-12 -$2.372026-06 $0.92-138.8% over the window
FCF (ttm): 178.4M2017-12 -10.1M2026-06 178.4M-1868.6% over the window
FCF/share: $2.322017-12 -$1.782026-06 $2.32-230.9% over the window
Book value/share: $5.912017-12 -$17.192026-06 $5.91-134.4% over the window
Net margin: 6.00%2017-12 -25.6%2026-06 6.0%-123.4% over the window
ROE: 17.35%2019-12 -7.5%2026-06 17.3%-331.3% over the window
ROA: 10.98%2018-12 1.6%2026-06 11.0%+586.7% over the window
Current ratio: 2.142018-12 0.812026-06 2.14+163.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: +5.54%2025-06-30 → 2026-06-301.2B → 1.3B (+5.5% total)+11.03%2023-06-30 → 2026-06-30957.5M → 1.3B (+36.9% total)+23.84%2021-06-30 → 2026-06-30450M → 1.3B (+191.3% total)n/a
Net income: +48.06%2025-06-30 → 2026-06-3053.1M → 78.6M (+48.0% total)+16.84%2023-06-30 → 2026-06-3049.3M → 78.6M (+59.5% total)+0.22%2021-06-30 → 2026-06-3077.8M → 78.6M (+1.1% total)n/a
FCF: -6.21%2025-06-30 → 2026-06-30190.2M → 178.4M (-6.2% total)+2.55%2023-06-30 → 2026-06-30165.4M → 178.4M (+7.8% total)+66.66%2021-06-30 → 2026-06-3013.9M → 178.4M (+1185.2% total)n/a
Shares: -10.77%2025-06-30 → 2026-06-3086M → 76.7M (-10.8% total)-7.00%2023-06-30 → 2026-06-3095.4M → 76.7M (-19.6% total)-3.01%2021-06-30 → 2026-06-3089.4M → 76.7M (-14.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

EPS: +55.98%2025-06-30 → 2026-06-30$0.59 → $0.92 (+55.9% total)+23.36%2023-06-30 → 2026-06-30$0.49 → $0.92 (+87.8% total)+3.36%2021-06-30 → 2026-06-30$0.78 → $0.92 (+17.9% total)n/a
Sales/share: +18.28%2025-06-30 → 2026-06-30$14.44 → $17.08 (+18.3% total)+19.40%2023-06-30 → 2026-06-30$10.04 → $17.08 (+70.2% total)+27.69%2021-06-30 → 2026-06-30$5.03 → $17.08 (+239.4% total)n/a
FCF/share: +5.11%2025-06-30 → 2026-06-30$2.21 → $2.32 (+5.1% total)+10.27%2023-06-30 → 2026-06-30$1.73 → $2.32 (+34.1% total)+71.83%2021-06-30 → 2026-06-30$0.16 → $2.32 (+1397.4% total)n/a
Book value/share: -1.38%2025-06-30 → 2026-06-30$5.99 → $5.91 (-1.4% total)+6.28%2023-06-30 → 2026-06-30$4.92 → $5.91 (+20.0% total)+20.89%2021-06-30 → 2026-06-30$2.29 → $5.91 (+158.2% total)n/a
Price: +45.63%2025-10-20 → 2026-10-20$19.63 → $28.58 (+45.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-3.36%2023-10-20 → 2026-10-20$31.67 → $28.58 (-9.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-13.51%2021-10-20 → 2026-10-20$59.04 → $28.58 (-51.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +45.63%2025-10-20 → 2026-10-20$19.63 → $28.58 (+45.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.36%2023-10-20 → 2026-10-20$31.67 → $28.58 (-9.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-13.51%2021-10-20 → 2026-10-20$59.04 → $28.58 (-51.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 31.1×2019-12 -271.772026-10 27.89-110.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.6×2019-12 240.662026-10 19.56-91.9% over the window
Fwd P/E: 12.0×
P/S (ttm)Market cap ÷ TTM revenue.: 1.7×2019-12 10.142026-10 1.67-83.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.8×2019-12 20.382026-10 4.84-76.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 12.3×2019-12 -518.672026-10 12.29-102.4% over the window
EV/EBITDA (fy): 17.5×
EV/Sales (ttm): 1.6×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.13%2019-09 0.3%2026-06 8.1%+2510.2% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 76.7M ÷ 86.0M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 10.77%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (10.77%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 10.77%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($230.3M) ÷ today's market cap ($2.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 10.50%2019-09 0.0%2026-06 10.4%+133112.2% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $230.3M + TTM dividends $0) ÷ today's market cap ($2.2B). Same caveat as the cash buyback yield.: 10.50%2019-09 0.0%2026-06 10.4%+133112.2% over the window

Vs own 10Y history

P/E: 12th
P/OI: 8th
P/S: 26th
P/B: 33rd
P/FCF: 31st

Bar = where today’s multiple sits in PGNY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.66%

+4.34%

+5.34%

-10.04%

YTD

+11.29%

+45.59%

-51.59%

Financial statements

Open full PGNY financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

PGNY — Progyny Inc. price, chart and key statistics